Lunai Bioworks Inc. Financing Cash Flow
Lunai Bioworks Inc. (LNAI) reported Financing Cash Flow of $6.00 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-05-15
- Lunai Bioworks Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.70M, a 3.33% increase year-over-year.
- Lunai Bioworks Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $950.00K, a 63.33% decline year-over-year.
- Lunai Bioworks Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.34M, a 33.80% decline year-over-year.
- Lunai Bioworks Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $178.36K, a 92.77% decline year-over-year.
- Lunai Bioworks Inc. net cash provided by (used in) financing activities for fiscal 2025 was $8.38M, a 20.30% decline from fiscal 2024.
- Lunai Bioworks Inc. net cash provided by (used in) financing activities for fiscal 2024 was $10.52M, a 132.94% increase from fiscal 2023.
- Lunai Bioworks Inc. net cash provided by (used in) financing activities for fiscal 2023 was $4.52M, a 6.23% increase from fiscal 2022.
- Lunai Bioworks Inc. net cash provided by (used in) financing activities for fiscal 2022 was $4.25M, a 86.96% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 2 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 8 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 11 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 14 month | Net Cash Provided by (Used in) Financing Activities 17 month | Net Cash Provided by (Used in) Financing Activities 20 month | Net Cash Provided by (Used in) Financing Activities 23 month | Net Cash Provided by (Used in) Financing Activities 26 month | Net Cash Provided by (Used in) Financing Activities 29 month | Net Cash Provided by (Used in) Financing Activities 32 month | Net Cash Provided by (Used in) Financing Activities 35 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $4.65M derived: sum of 2 quarters · filed 2026-05-15 | $6.00M 10-Q · filed 2026-05-15 | $6.18M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||
| 2025-12-31 | $950.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $2.29M 10-Q · filed 2026-02-17 | $2.47M derived: sum of 3 quarters · filed 2026-02-17 | $6.06M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||
| 2025-09-30 | $1.34M 10-Q · filed 2025-11-14 | $1.52M derived: sum of 2 quarters · filed 2025-11-14 | $5.11M derived: sum of 3 quarters · filed 2026-05-15 | $7.70M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||
| 2025-06-30 | $178.36K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $3.76M derived: sum of 2 quarters · filed 2026-05-15 | $6.35M derived: sum of 3 quarters · filed 2026-05-15 | $8.38M 10-K · filed 2025-09-29 | ||||||||||||
| 2025-03-31 | $3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $6.18M derived: sum of 2 quarters · filed 2026-05-15 | $8.20M 10-Q · filed 2026-05-15 | $10.67M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||
| 2024-12-31 | $2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $4.62M 10-Q · filed 2026-02-17 | $7.09M derived: sum of 3 quarters · filed 2026-02-17 | $9.73M derived: sum of 4 quarters · filed 2026-02-17 | ||||||||||||
| 2024-09-30 | $2.03M 10-Q · filed 2025-11-14 | $4.50M derived: sum of 2 quarters · filed 2025-11-14 | $7.14M derived: sum of 3 quarters · filed 2025-11-14 | $9.98M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||||
| 2024-06-30 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $5.11M derived: sum of 2 quarters · filed 2025-09-29 | $7.95M derived: sum of 3 quarters · filed 2025-09-29 | $10.52M 10-K · filed 2025-09-29 | ||||||||||||
| 2024-03-31 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $5.49M derived: sum of 2 quarters · filed 2025-05-15 | $8.05M 10-Q · filed 2025-05-15 | $9.30M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||
| 2023-12-31 | $2.85M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-02-19 | $5.41M 10-Q · filed 2025-02-19 | $6.66M derived: sum of 3 quarters · filed 2025-02-19 | $8.77M derived: sum of 4 quarters · filed 2025-02-19 | ||||||||||||
| 2023-09-30 | $2.56M 10-Q/A · filed 2025-02-19 | $3.81M derived: sum of 2 quarters · filed 2025-02-19 | $5.92M derived: sum of 3 quarters · filed 2025-02-19 | $5.62M derived: sum of 4 quarters · filed 2025-02-19 | ||||||||||||
| 2023-06-30 | $1.25M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-02-19 | $3.36M derived: sum of 2 quarters · filed 2025-02-19 | $3.06M derived: sum of 3 quarters · filed 2025-02-19 | $4.52M 10-K/A · filed 2025-02-19 | ||||||||||||
| 2023-03-31 | $2.11M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2025-02-19 | $1.81M derived: sum of 2 quarters · filed 2025-02-19 | $3.27M 10-Q/A · filed 2025-02-19 | $4.34M derived: sum of 4 quarters · filed 2025-02-19 | ||||||||||||
| 2022-12-31 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $1.16M 10-Q · filed 2024-02-14 | $2.23M derived: sum of 3 quarters · filed 2024-02-14 | $2.46M derived: sum of 4 quarters · filed 2024-02-14 | ||||||||||||
| 2022-09-30 | $1.46M 10-Q · filed 2023-11-14 | $1.63M 10-Q · filed 2023-03-07 | $2.53M derived: sum of 2 quarters · filed 2023-11-14 | $2.76M derived: sum of 3 quarters · filed 2023-11-14 | $5.71M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||
| 2022-06-30 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-02 | $1.30M derived: sum of 2 quarters · filed 2023-10-02 | $4.25M derived: sum of 3 quarters · filed 2023-10-02 | $4.25M 10-K · filed 2023-10-02 | ||||||||||||
| 2022-03-31 | $229.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | $3.18M derived: sum of 2 quarters · filed 2023-05-12 | $3.18M 10-Q · filed 2023-05-12 | $32.38M derived: sum of 4 quarters · filed 2023-05-12 | ||||||||||||
| 2021-12-31 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-09 | $2.95M 10-Q · filed 2023-03-09 | $32.15M derived: sum of 3 quarters · filed 2023-03-09 | $35.59M derived: sum of 4 quarters · filed 2023-03-09 | ||||||||||||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $29.20M derived: sum of 2 quarters · filed 2023-02-27 | $32.64M derived: sum of 3 quarters · filed 2023-02-27 | $32.60M derived: sum of 4 quarters · filed 2023-02-27 | ||||||||||||
| 2021-06-30 | $29.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $32.64M derived: sum of 2 quarters · filed 2023-02-27 | $32.60M derived: sum of 3 quarters · filed 2023-02-27 | $32.60M 10-K · filed 2023-02-27 | ||||||||||||
| 2021-03-31 | $3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $3.40M derived: sum of 2 quarters · filed 2022-05-13 | $3.40M 10-Q · filed 2022-05-13 | $3.40M derived: sum of 4 quarters · filed 2022-05-13 | ||||||||||||
| 2020-12-31 | -$40.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | -$40.41K 10-Q · filed 2022-02-14 | -$40.41K derived: sum of 3 quarters · filed 2022-02-14 | $6.16M derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $6.20M derived: sum of 3 quarters · filed 2021-11-15 | $6.20M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-24 | $6.20M derived: sum of 2 quarters · filed 2021-09-24 | $6.20M derived: sum of 3 quarters · filed 2021-09-24 | $7.20M 10-K · filed 2021-09-24 | ||||||||||||
| 2020-03-31 | $6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $6.20M derived: sum of 2 quarters · filed 2021-05-17 | $7.20M 10-Q · filed 2021-05-17 | $11.52M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||||
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $1.00M 10-Q · filed 2021-02-16 | $5.32M derived: sum of 3 quarters · filed 2021-02-16 | $5.32M derived: sum of 4 quarters · filed 2021-02-16 | ||||||||||||
| 2019-09-30 | $1.00M 10-Q · filed 2020-11-12 | $5.32M derived: sum of 2 quarters · filed 2020-11-12 | $5.32M derived: sum of 3 quarters · filed 2020-11-12 | |||||||||||||
| 2019-06-30 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | $4.32M derived: sum of 2 quarters · filed 2020-09-23 | $6.02M 10-K · filed 2020-09-23 | |||||||||||||
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $1.70M 10-Q · filed 2020-05-11 | ||||||||||||||
| 2018-12-31 | $1.70M 10-Q · filed 2020-02-10 | |||||||||||||||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30 | $11.90M derived: sum of 2 quarters · filed 2019-09-30 | $16.72M derived: sum of 3 quarters · filed 2019-09-30 | $16.71M 10-K · filed 2019-09-30 | ||||||||||||
| 2018-03-31 | $11.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-16 | $16.72M derived: sum of 2 quarters · filed 2019-05-16 | $16.71M 10-Q · filed 2019-05-16 | $21.81M derived: sum of 4 quarters · filed 2019-05-16 | ||||||||||||
| 2017-12-31 | $4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | $4.81M 10-Q · filed 2019-02-13 | $9.91M derived: sum of 3 quarters · filed 2019-02-13 | $9.96M derived: sum of 4 quarters · filed 2019-02-13 | ||||||||||||
| 2017-09-30 | -$4.50K 10-Q · filed 2018-11-14 | $5.09M derived: sum of 2 quarters · filed 2018-11-14 | $5.14M derived: sum of 3 quarters · filed 2018-11-14 | |||||||||||||
| 2017-06-30 | $5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-01 | $5.15M derived: sum of 2 quarters · filed 2018-10-01 | $5.51M 10-K · filed 2018-10-01 | |||||||||||||
| 2017-03-31 | $52.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | $413.67K 10-Q · filed 2017-05-15 | ||||||||||||||
| 2016-12-31 | $360.90K 10-Q · filed 2018-02-09 | |||||||||||||||
| 2016-09-30 | $360.90K 10-Q · filed 2016-11-14 | |||||||||||||||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-13 | $5.28M derived: sum of 2 quarters · filed 2016-05-13 | $5.81M 10-Q · filed 2016-05-13 | $5.80M derived: sum of 4 quarters · filed 2016-05-13 | ||||||||||||
| 2014-12-31 | $5.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | $5.81M 10-Q · filed 2016-02-12 | $5.80M derived: sum of 3 quarters · filed 2016-02-12 | $6.67M 10-K · filed 2016-09-28 | ||||||||||||
| 2014-09-30 | $529.59K 10-Q · filed 2015-11-13 | $522.38K derived: sum of 2 quarters · filed 2015-11-13 | $1.39M 10-Q · filed 2014-11-13 | $1.39M derived: sum of 4 quarters · filed 2015-11-13 | ||||||||||||
| 2014-06-30 | -$7.21K derived: 10-KT 6 month − 10-Q 3 month · filed 2015-09-28 | $858.76K 10-KT · filed 2015-09-28 | $862.41K derived: sum of 3 quarters · filed 2015-09-28 | $871.90K derived: sum of 4 quarters · filed 2015-09-28 | ||||||||||||
| 2014-03-31 | $865.98K 10-Q · filed 2015-05-13 | $869.63K derived: sum of 2 quarters · filed 2015-05-13 | $879.11K derived: sum of 3 quarters · filed 2015-05-13 | $879.61K derived: sum of 4 quarters · filed 2015-05-13 | ||||||||||||
| 2013-12-31 | $3.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-11 | $13.13K derived: sum of 2 quarters · filed 2014-02-11 | $13.63K 10-Q · filed 2014-02-11 | $2.47M 10-KT · filed 2015-09-28 | $88.63K 10-Q · filed 2014-02-11 | |||||||||||
| 2013-09-30 | $9.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-15 | $9.98K 10-Q · filed 2013-11-15 | $1.98M 10-Q · filed 2014-11-13 | $1.01M derived: sum of 4 quarters · filed 2014-05-14 | $84.98K 10-Q · filed 2013-11-15 | |||||||||||
| 2013-06-30 | $500.00 10-Q · filed 2013-08-15 | $1.27M 10-Q · filed 2014-08-14 | $995.91K derived: sum of 3 quarters · filed 2014-05-14 | $1.00M derived: sum of 4 quarters · filed 2014-05-14 | $75.50K 10-Q · filed 2013-08-15 | |||||||||||
| 2013-03-31 | $987.91K 10-Q · filed 2014-05-14 | $995.41K derived: sum of 2 quarters · filed 2014-05-14 | $1.00M derived: sum of 3 quarters · filed 2014-05-14 | $36.50K 10-K · filed 2013-07-16 | $75.00K 10-K · filed 2013-07-16 | |||||||||||
| 2012-12-31 | $7.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-11 | $16.50K derived: sum of 2 quarters · filed 2014-02-11 | $27.50K 10-Q · filed 2014-02-11 | $856.75K 10-Q · filed 2014-08-14 | $66.00K 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-15 | $20.00K 10-Q · filed 2013-11-15 | $25.00K derived: sum of 3 quarters · filed 2013-11-15 | $28.50K derived: sum of 4 quarters · filed 2013-11-15 | $58.50K 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $11.00K 10-Q · filed 2013-08-15 | $16.00K derived: sum of 2 quarters · filed 2013-08-15 | $19.50K derived: sum of 3 quarters · filed 2013-08-15 | $44.50K derived: sum of 4 quarters · filed 2013-08-15 | $49.50K 10-Q · filed 2012-08-20 | |||||||||||
| 2012-03-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-16 | $8.50K derived: sum of 2 quarters · filed 2013-07-16 | $33.50K derived: sum of 3 quarters · filed 2013-07-16 | $38.50K 10-K · filed 2013-07-16 | $38.50K 10-K · filed 2012-07-17 | |||||||||||
| 2011-12-31 | $3.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | $28.50K derived: sum of 2 quarters · filed 2013-02-14 | $33.50K 10-Q · filed 2013-02-14 | $33.50K 10-Q · filed 2012-02-21 | ||||||||||||
| 2011-09-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-14 | $30.00K 10-Q · filed 2012-11-14 | $30.00K 10-Q · filed 2011-11-25 | |||||||||||||
| 2011-06-30 | $5.00K 10-Q · filed 2012-08-20 | |||||||||||||||
| 2011-03-31 | $0.00 10-K · filed 2012-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |